CannaEvidence
Is this for me?
Is this for me?

Europe · all countries · model D — Named-patient or exceptional access

Medical cannabis in Sweden

Per-patient licence via pharmacy application

A new patient cannot obtain cannabis flower or extracts in Sweden on an ordinary prescription: apart from the approved medicines Sativex and Epidyolex, a doctor must justify a 'licens' (special permit) that a pharmacy applies for at Läkemedelsverket for that named patient.

The hardest fact about Sweden. Every unapproved cannabis product needs an individual licence decision by Läkemedelsverket, and Sweden's drug-driving law is zero-tolerance for THC in blood, with a defence only for medicines taken as prescribed.

Every answer below was read in the law, the register or the official statistic itself. This country is part of the Europe layer: an English page of verified facts, no directory. Where an answer is marked as not published, no official source states it — we did not fill the gap with a guess.

The questions, answered for Sweden

How access works here

The one-line answer: can a new patient start today, and through what.

D — named-patient / exceptional. Unapproved cannabis products are sold only under a 'licens' (special permit): a temporary sales permit for one pharmacy to sell a specific unapproved product to a named patient, granted by Läkemedelsverket (Swedish Medical Products Agency) on the basis of a prescriber's justification.

Legal basis: Läkemedelslag (2015:315) (Medicines Act) 4 kap. 10 §: 'Om det finns särskilda skäl, får tillstånd till försäljning av ett läkemedel lämnas även i andra fall än som avses i 2, 4-7 och 9 §§'; 4 kap. 11 § lets the Government delegate the decision to Läkemedelsverket. Läkemedelsverket describes the licence as 'a temporary sales permit for a pharmacy to sell a specific medicinal product without Swedish market authorization' (applies to named patients or healthcare units; applications are submitted by pharmacies through KLAS after the prescriber's clinical justification). Läkemedelsverket's own cannabis pages are JavaScript-only and could not be read in this session, so product-specific licence practice is not documented here.

Source: Riksdagen — Läkemedelslag (2015:315), 4 kap. 10 § · read 27 September 2026

What may be prescribed

What the law allows a doctor to write on a prescription here.

Two cannabinoid medicines are authorised: Epidyolex (cannabidiol, EU-wide authorisation) and Sativex (THC/CBD spray). Any flower or extract product requires an individual licence; there is no official product list.

Epidyolex (cannabidiol) has a centralised EU marketing authorisation since 19 September 2019 (Jazz Pharmaceuticals Ireland Ltd) for seizures in Lennox-Gastaut, Dravet and tuberous sclerosis complex, valid in Sweden. Sativex's Swedish national authorisation could not be confirmed on an official Swedish page in this session (Läkemedelsverket's product database is JavaScript-only). Unapproved cannabis products (e.g. Dutch flower) can only be dispensed under a Läkemedelsverket licence; the agency publishes no positive list.

Source: EMA — Epidyolex EPAR · read 27 September 2026

Who may prescribe

Whether you need a specialist, and whether anyone has to approve it first.

Not published

Any licensed doctor may write the justification for a licence application, but Läkemedelsverket decides each case; there is no state list of cannabis prescribers and no automatic right to a licence.

Lag (1992:860) om kontroll av narkotika (Narcotics Control Act) 6 §: 'Narkotiska läkemedel får lämnas ut endast efter förordnande av läkare, tandläkare eller veterinär.' The licence itself is granted to a pharmacy for a named patient under Läkemedelslagen 4 kap. 10 § on 'särskilda skäl'. Whether Läkemedelsverket restricts cannabis licences to specialists is stated only on its JavaScript-rendered pages, which could not be opened — not verified.

Source: Riksdagen — Lag (1992:860) om kontroll av narkotika · read 27 September 2026

Type of prescription

The form itself: which prescription, how long it is valid, how much it covers.

Cannabis medicines are narcotic prescription medicines dispensed only on a doctor's order; Swedish prescriptions are electronic and usually valid for one year. Specific narcotic-prescription formalities could not be verified from the regulator this session.

Narcotics Control Act 6 § requires a prescription from a doctor, dentist or veterinarian. 1177 (the regions' official health portal, updated 27 April 2023): 'Ett recept är oftast giltigt i ett år men det kan även vara kortare tid.' The detailed rules for 'särskilda läkemedel' (special medicines incl. narcotics) sit in Läkemedelsverket's föreskrifter HSLF-FS 2021:75, whose PDF is blocked to automated access; quantity limits and one-time-dispensing rules are therefore not documented here.

Source: 1177 — När du får ett recept · read 27 September 2026

Telemedicine

Whether a prescription can lawfully begin in a video call.

Not published

No official rule specific to cannabis and video consultations was found; the practical gate is the individual licence decision by Läkemedelsverket, not the consultation format.

Neither the statutes opened (Läkemedelslagen, Narcotics Control Act) nor the accessible regulator pages address whether a licence justification may be based on a video consultation. Not published in any source opened this session.

Source: Riksdagen — Läkemedelslag (2015:315) · read 27 September 2026

Dispensing

Which pharmacy can actually hand it over.

The licence is granted to a specific pharmacy, which then orders and dispenses the product to the named patient; any Swedish pharmacy can apply. Mail-order rules for narcotic licence products were not verified.

Läkemedelsverket: the special permit is 'a temporary sales permit for a pharmacy to sell a specific medicinal product without Swedish market authorization', applied for by pharmacies via KLAS. No official register marks cannabis-dispensing pharmacies.

Source: Läkemedelsverket — Special permit (licens) page (meta text only; body requires JavaScript) · read 27 September 2026

Reimbursement

Whether anyone other than you pays for it.

Not published

Licence medicines can be included in the pharmaceutical benefits (high-cost protection) without the usual TLV assessment, but whether cannabis flower or Sativex actually are reimbursed could not be verified from TLV this session.

Lag (2002:160) om läkemedelsförmåner m.m. (Pharmaceutical Benefits Act, last amended SFS 2025:578) 16 §: 'Ett läkemedel som får säljas enligt 4 kap. 10 § ... läkemedelslagen (2015:315) får ingå i läkemedelsförmånerna utan att villkoren i 15 § är uppfyllda', with Government regulations on conditions and pricing. TLV's page on licensläkemedel and its decisions on Sativex/Epidyolex could not be opened (robots/timeout), so the actual reimbursement status of cannabis products is not confirmed.

Source: Riksdagen — Lag (2002:160) om läkemedelsförmåner m.m., 16 § · read 27 September 2026

What it costs

What you pay, as far as anyone publishes it.

Not published

No official price for cannabis licence products or Sativex/Epidyolex was retrievable from TLV's price database in this session.

TLV (Tandvårds- och läkemedelsförmånsverket, Dental and Pharmaceutical Benefits Agency) publishes prices for reimbursed medicines in its database, but the site's subpages were unreachable (robots.txt fetch failures). No public price is documented here.

Source: TLV — homepage (database reference) · read 27 September 2026

Driving

The question with the worst consequences and the least reliable information online.

Sweden is zero-tolerance: driving with any narcotic substance in the blood is 'rattfylleri' — except when the narcotic was taken according to a doctor's prescription. A prescribed cannabis medicine therefore gives a defence, but you can still be convicted if you are actually impaired.

Lag (1951:649) om straff för vissa trafikbrott (Road Traffic Offences Act, last amended SFS 2024:715) 4 §: 'För rattfylleri enligt första stycket döms också den som för ett motordrivet fordon eller en spårvagn efter att ha intagit narkotika som avses i 8 § narkotikastrafflagen (1968:64) i så stor mängd att det under eller efter färden finns något narkotiskt ämne kvar i blodet. Detta gäller dock inte om narkotikan intagits i enlighet med läkares eller annan behörig receptutfärdares ordination.' Impairment-based rattfylleri and grovt rattfylleri (4 a §, up to 2 years) still apply regardless of prescription.

Source: Riksdagen — Lag (1951:649) om straff för vissa trafikbrott, 4 § · read 27 September 2026

Travel

Taking it across a border, which is where most published advice is simply wrong.

Travellers from Schengen states may bring narcotic medicines for personal medical use for up to 30 days' consumption, with a Schengen certificate for listed substances issued by a pharmacy. For non-Schengen arrivals the law allows personal medical import but the quantity rules are in Läkemedelsverket regulations not readable here.

Förordning (1992:1554) om kontroll av narkotika (Narcotics Control Ordinance, last amended SFS 2026:1109) 5 a §: a traveller from a Schengen state may bring narcotic medicines without permit 'om läkemedlen är avsedda för medicinskt ändamål och den resandes personliga bruk, och läkemedlen vid varje enskild inresa medförs i en mängd som står i relation till resans längd och inte i något fall överskrider vad som motsvarar 30 dagars förbrukning'; 5 b §: pharmacy staff issue the Schengen Art. 75 certificate for Annex-2 substances; 5 c §: Läkemedelsverket provides forms free of charge. Lag (1992:860) 3 § second paragraph allows 'resande' generally to bring in narcotic medicines for personal medical use; the ordinance's 4 § otherwise requires a permit per case. Läkemedelsverket's 'Travelling with medicines' and Tullverket's 'Resa med medicin' pages exist but their body text was not retrievable.

Source: Riksdagen — Förordning (1992:1554) om kontroll av narkotika, 5 a–5 c §§ · read 27 September 2026

As a visitor or new resident

Four things nobody publishes together: getting a prescription as a non-resident, using a prescription from another EU country, bringing your own medicine in, and whether a foreign video consultation counts.

A non-resident faces the same individual-licence gate as a resident. Swedish pharmacies can dispense EEA prescriptions, but the exclusions for narcotic and licence medicines are in a regulation that could not be read here; bring your own medicine under the Schengen 30-day rule instead.

(1) Non-residents: no legal bar found; any unapproved cannabis product needs a Läkemedelsverket licence for the named patient (Läkemedelslagen 4 kap. 10 §). (2) Foreign EEA prescriptions: Läkemedelsverket confirms 'Svenska apotek kan expediera recept från andra länder inom det Europeiska ekonomiska samarbetsområdet (EES)' (meta text of the 'Recept inom EES' page). The exclusions implementing Directive 2011/24/EU Art. 11(6) — narcotics/'särskilda läkemedel' and licence medicines — are in HSLF-FS 2021:75 (Läkemedelsverkets föreskrifter om förordnande och utlämnande av läkemedel och teknisk sprit), whose PDF is blocked to automated access: not verified. Because a licence product is not an approved medicine in Sweden, a foreign cannabis prescription cannot be dispensed without a Swedish licence in any case. (3) Bringing medicine in: Schengen residents up to 30 days' consumption with pharmacy-issued Schengen certificate (Förordning 1992:1554, 5 a–5 b §§); non-Schengen quantity rules not published in sources opened. (4) Foreign telemedicine prescriptions: follow from (2) — not dispensable for unapproved cannabis products; for Sativex/Epidyolex not verified.

Source: Läkemedelsverket — Recept inom EES (meta text only; body requires JavaScript) · read 27 September 2026

What is changing

What is pending in parliament or at the regulator, with dates — or the statement that nothing is.

Not published

No pending change to the licence model for cannabis was identified in the statutes opened; the Narcotics Control Ordinance was last amended in 2026 (SFS 2026:1109) without changing the traveller rules quoted.

Riksdagen shows Förordning (1992:1554) amended by SFS 2026:1109, Lag (1992:860) by SFS 2024:818, Trafikbrottslagen by SFS 2024:715 and Läkemedelsförmånslagen by SFS 2025:578. Läkemedelsverket news on cannabis could not be read (JavaScript-only), so any agency-level policy change is not captured.

Source: Riksdagen — Förordning (1992:1554) om kontroll av narkotika · read 27 September 2026

Number of patients

How many people this actually concerns — where anyone counts.

Not published

No official count of cannabis licences or patients could be retrieved this session.

Läkemedelsverket publishes licence statistics on its JavaScript-only site, which returned no body text. No other official source with numbers was opened.

Source: Läkemedelsverket — Special permit (licens) page · read 27 September 2026

What we can publish for Sweden, and what we cannot

Four directories, four honest answers. Where an official register exists we republish it and link every entry back to the source. Where none exists, that is what the page says — a list built out of self-declarations would be worse than no list, and saying so is more useful to you than pretending.

Doctors

No list — by design

No state list of cannabis prescribers; Socialstyrelsen's general practitioner register does not identify who writes licence justifications.

Pharmacies

No list — by design

Licences are granted to whichever pharmacy applies; no official register marks cannabis-dispensing pharmacies.

Products and preparations

No list — by design

No official positive list: each unapproved product is licensed per patient and pharmacy; Läkemedelsverket does not publish a cannabis product register.

Telemedicine platforms

No list — by design

No official register of telehealth providers and no published rule enabling online cannabis licensing.

Where this country's law lives

Everything above comes from these texts rather than from another portal's summary. They are listed so you can check us.

Crossing a border with this

Two European rules decide most of what a traveller asks. Directive 2011/24/EU obliges pharmacies to honour prescriptions from another Member State — but only for medicines authorised in the dispensing country, and its Article 11(6) says the rule “shall not apply to medicinal products subject to special medical prescription”, which is where narcotic prescriptions sit. A magistral cannabis preparation is neither authorised nor outside that exclusion, so a cannabis prescription from another country is, as a rule, not dispensable anywhere in Europe. For carrying your own medicine, Article 75 of the Schengen Convention lets a resident of a Schengen state travel with a certified supply for up to 30 days; outside Schengen, national import rules apply. The country-specific answer is above under “As a visitor or new resident”.

Directive 2011/24/EU, Article 11(1) and 11(6) — read on EUR-Lex on 27 September 2026: CELEX 32011L0024.

Other countries with the same model (named-patient or exceptional access)

The answers change at every border, and a prescription does not travel with you. Compare before you assume.